September 7, 2022
Experienced medical device professionals can agree that investing in quality early on and putting it at the forefront of building a company can give you a competitive advantage. Whether it be an early-stage company or one with a device already on the market, taking a quality-first approach by establishing a robust electronic Quality Management System
March 15, 2022
About a year and a half ago, Hemostatix Medical Technologies, a Bartlett-based company, was in talks with a big medical device company regarding an acquisition. The larger, undisclosed company was interested in Hemostatix’s intellectual property — a unique thermal scalpel that seals blood vessels as they are incised, effectively enabling cutting and coagulating at the
March 9, 2022
KALAMAZOO, Mich., March 8, 2022 /PRNewswire/ — C2Dx, a privately held medical device company, announced its acquisition of Hemostatix Medical Technologies LLC (Hemostatix) effective on January 1, 2022. This latest expansion aligns with C2Dx’s strategy to invest in and refine the delivery of valuable niche products to propel their growth and accessibility worldwide. The acquisition
January 21, 2022
Kalamazoo-based medical device startup C2Dx was founded by Kevin McLeod and Ann Arbor-based growth capital firm Plymouth Growth in 2019 to invest in and refine the delivery of “valuable niche products” to propel its growth. And that’s exactly what happened in 2021. C2Dx’s second product acquisition occurred early last year when it purchased Stryker’s T/Pump
December 16, 2021
The Grand Rapids Business Journal has selected the finalists for its 2021 Newsmaker of the Year awards. The 48 finalists in 16 categories will be celebrated on Jan. 26 during a breakfast event at Frederik Meijer Gardens and Sculpture Park. The Newsmaker show represents the first event in the Business Journal’s new Breakfast Series lineup,
August 31, 2021
KALAMAZOO, Mich., Aug. 31, 2021 /PRNewswire/ — C2Dx Inc., a medical device company that invests in and refines the delivery of valuable, niche products to propel their growth and accessibility, has partnered with another Michigan startup – Quintree. The telemedicine platform that integrates with existing diagnostic equipment is launching to healthcare providers. C2Dx Now Providing
July 6, 2021
C2Dx, Inc is a privately held medical device company based in Kalamazoo, Michigan with a unique business model. Founded in early 2019 by industry experts, C2Dx continues to build its business from the strong foundation of its initial acquisition of the STIC Intra-Compartmental Pressure Monitor from Stryker. Seeing success from giving this product dedicated attention
February 18, 2021
A medical device startup acquired a line of devices that provide localized temperature therapy for pain relief and patient comfort. Kalamazoo-based C2Dx — a medical device company founded in 2019 that invests in and refines the delivery of “valuable niche products” to propel their growth — said Tuesday that it acquired the T/Pump product line
February 17, 2021
Medical device company C2Dx Inc. has acquired the T/Pump product line from Stryker Corp. Both firms are based in Kalamazoo, which has become a medical technology powerhouse highlighted by the COVID-19 vaccine being produced by Pfizer. Kalamazoo also is home to multiple medical technology parks, Western Michigan University, and is a large producer of medical
February 16, 2021
C2Dx-StrykerC2Dx today announced that it has acquired Stryker’s T/Pump product line for an undisclosed amount. The T/Pump product line provides localized temperature therapy for pain relief and patient comfort. It is used for orthopedic conditions, acute injuries, chronic pain and muscle strains. It can also be used for skin trauma, burns, contusions and other localized